Search

Author/Creator Pelletier, Jeffrey

1. Development of an orally bioavailable stress kinase inhibitor with brain exposure that targets the neuroinflammation‐synaptic dysfunction pathophysiology axis: Human/Human trials: Other. (7th December 2020)

Authors:
Watterson, Daniel Martin; Arancio, Ottavio; Windisch, Manfred; Pelletier, Jeffrey; Roy, Saktimayee M.
Journal:
Alzheimer's & dementia
Issue:
Volume 16(2020)Supplement 9
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search